Cairo – Mubasher: Ibnsina Pharma recorded an 18.3% year-on-year (YoY) decrease in its net profits, logging EGP 200.6 million in the first nine months of 2020, compared to EGP 245.6 million.

The company’s sales grew to EGP 14.08 billion in the January-September period from EGP 12.2 billion in the year-ago period, according to a bourse disclosure on Sunday.

During the first half (H1) of 2020, Ibnsina Pharma posted net profits of EGP 88.9 million, down from EGP 103.19 million in H1-19.